Disulfiram and cancer immunotherapy: Advanced nano-delivery systems and potential therapeutic strategies
The initial focus of the clinical application of disulfiram was its efficacy in treating alcoholism. However, recent research has revealed its potential as an anti-tumor agent and even as an enhancer of cancer immunotherapy. Disulfiram has received safety approval from the FDA, indicating its safety...
Saved in:
| Main Authors: | Di Huang, Yinsha Yao, Yifei Lou, Longfa Kou, Qing Yao, Ruijie Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | International Journal of Pharmaceutics: X |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2590156724000793 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
AuCePt porous hollow cascade nanozymes targeted delivery of disulfiram for alleviating hepatic insulin resistance
by: Huawei Shen, et al.
Published: (2024-10-01) -
Disulfiram-induced polyneurophaty
by: Vujisić Slavica, et al.
Published: (2012-01-01) -
Combating cancer immunotherapy resistance: a nano‐medicine perspective
by: Xiangyi Kong, et al.
Published: (2025-07-01) -
Innovations in Cancer Immunotherapy Drug Delivery Technologies: A Systematic Review
by: Kavita Sharma, et al.
Published: (2025-05-01) -
Drug Delivery Systems Based on Metal–Organic Frameworks for Tumor Immunotherapy
by: Ning Yang, et al.
Published: (2025-02-01)